Concepedia

HJ Woerle

HW

4

Publications

138

Citations

4

H-Index

2007

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Rochester

HJ Woerle is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacotherapy, and diabetes.

Top concepts

DiabetesMedicinePharmacologyClinical TrialsPharmacotherapyClinical EpidemiologyHealthUrologyEpidemiologyHealth Policy

Publications per year

2007–2016

4

Publications

4

Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans

HJ Woerle, Max Albrecht, R. Linke et al. · American Journal of Physiology-Endocrinology and Metabolism · 2007 · 62 citations

Empagliflozin improves glycemic parameters and cardiovascular risk factors in patients with Type 2 Diabetes (T2DM): Pooled data from four pivotal phase III trials

Thomas Hach, John E. Gerich, Afshin Salsali et al. · Diabetologie und Stoffwechsel · 2014 · 41 citations

Bmi 28.7, Pharmacotherapy, Glycemic Parameters +19

Empagliflozin (EMPA) increases genital infections but not Urinary Tract Infections (UTIs) in pooled data from four pivotal phase III trials

G Kim, J. E. Gerich, Afshin Salsali et al. · Diabetologie und Stoffwechsel · 2014 · 21 citations

Empa 25, Pharmacotherapy, ± Metformin +17

Safety and tolerability of empagliflozin in patients with type 2 diabetes

Sven Köhler, Afshin Salsali, Stefan Hantel et al. · Diabetologie und Stoffwechsel · 2016 · 14 citations

Rows per page

1–4 of 4